Steris Plc (STE) concluded trading on Thursday at a closing price of $222.23, with 0.45 million shares of worth about $100.3 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.97% during that period and on April 17, 2025 the price saw a gain of about 1.00%. Currently the company’s common shares owned by public are about 98.25M shares, out of which, 97.90M shares are available for trading.
Stock saw a price change of 2.35% in past 5 days and over the past one month there was a price change of -1.35%. Year-to-date (YTD), STE shares are showing a performance of 8.11% which increased to 11.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $197.82 but also hit the highest price of $248.24 during that period. The average intraday trading volume for Steris Plc shares is 574.31K. The stock is currently trading 0.57% above its 20-day simple moving average (SMA20), while that difference is down -0.31% for SMA50 and it goes to -0.89% lower than SMA200.
Steris Plc (NYSE: STE) currently have 98.25M outstanding shares and institutions hold larger chunk of about 94.37% of that.
The stock has a current market capitalization of $21.83B and its 3Y-monthly beta is at 0.94. PE ratio of stock for trailing 12 months is 47.13, while it has posted earnings per share of $4.72 in the same period. Its PEG reads 4.58 and has Quick Ratio of 1.40 while making debt-to-equity ratio of 0.36. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for STE, volatility over the week remained 2.37% while standing at 3.11% over the month.
Analysts are in expectations that Steris Plc (STE) stock would likely to be making an EPS of 2.6 in the current quarter, while forecast for next quarter EPS is 2.3 and it is 9.87 for next year. For the current quarter EPS, analysts have given the company a lowest target 2.55 which is 2.61 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 2.58 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 10.99% while it is estimated to increase by 9.95% in next year. EPS is likely to grow at an annualized rate of 10.28% for next 5-years, compared to annual growth of 1.36% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on October 24, 2024 offering an Overweight rating for the stock and assigned a target price range of between $230 and $260 to it. Coverage by KeyBanc Capital Markets stated Steris Plc (STE) stock as an Overweight in their note to investors on February 06, 2024, suggesting a price target of $253 for the stock. On May 30, 2023, Morgan Stanley Initiated their recommendations, while on April 14, 2023, Piper Sandler Downgrade their ratings for the stock with a price target of $197. Stock get a Hold rating from Needham on September 23, 2022.
